ChemAnalyst Data Pvt Ltd

North America In Q4 2024, the North American  Progesterone  API market experienced significant price declines, driven by lower production costs in major manufacturing hubs and weakened demand, which dampened trading sentiment. U.S. buyers postponed purchases, anticipating further price drops, while high domestic inventory levels forced suppliers to adopt aggressive pricing strategies. Additionally, a favorable USD/CNY exchange rate made Chinese imports more cost-effective, exerting further downward pressure on domestic prices. An influx of competitively priced Chinese exports, supported by favorable production economics and currency valuations, further impacted the market. On the demand side, procurement strategies focused on inventory optimization, as buyers worked through stockpiles from previous high-volume purchases. By December, the market remained bearish, with subdued procurement activity and weak demand across key downstream sectors. Intense price competition from Chin...

  The global progesterone market has witnessed substantial growth in recent years, driven by increasing demand from the pharmaceutical and healthcare sectors. Progesterone, a crucial hormone in reproductive health, is widely used in hormone replacement therapy (HRT), infertility treatments, and gynecological disorders. The rising prevalence of conditions such as polycystic ovary syndrome (PCOS), endometriosis, and hormonal deficiencies has significantly increased the demand for progesterone-based medications. Additionally, advancements in assisted reproductive technologies (ART) and growing awareness about hormone-related health issues have further contributed to market expansion. The increasing use of progesterone in the production of contraceptive drugs, as well as in veterinary applications, is another factor boosting demand. The  progesterone price  market is influenced by various factors, including raw material availability, manufacturing costs, and regulatory polici...